Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,129 | 139 | 99.3% |
| Education | $14.90 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $332.29 | 21 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $306.80 | 21 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $179.68 | 12 | $0 (2021) |
| Amgen Inc. | $124.87 | 9 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $123.18 | 9 | $0 (2021) |
| Lilly USA, LLC | $103.96 | 6 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $101.68 | 6 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $86.39 | 5 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $85.35 | 5 | $0 (2021) |
| Novo Nordisk Inc | $83.15 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $454.11 | 29 | Merck Sharp & Dohme Corporation ($87.33) |
| 2020 | $406.03 | 27 | PFIZER INC. ($126.93) |
| 2019 | $694.63 | 45 | Boehringer Ingelheim Pharmaceuticals, Inc. ($173.70) |
| 2018 | $368.49 | 23 | Boehringer Ingelheim Pharmaceuticals, Inc. ($63.35) |
| 2017 | $220.98 | 16 | PFIZER INC. ($73.15) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/12/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Gastroenterology | ||||||
| 10/09/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/13/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: PSYCHIATRY | ||||||
| 08/16/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Cardio-renal | ||||||
| 08/10/2021 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: UROLOGY | ||||||
| 07/12/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: RESPIRATORY | ||||||
| 06/21/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLUJAN | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/26/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Gastroenterology | ||||||
| 05/17/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLUJAN | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/06/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS, REYVOW | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: WOMENS HEALTH | ||||||
| 04/19/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLUJAN | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/05/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Diabetes | ||||||
| 04/01/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Cardiovascular | ||||||
| 03/30/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: PSYCHIATRY | ||||||
| 03/15/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLUJAN | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/11/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: UROLOGY | ||||||
| 03/08/2021 | PFIZER INC. | PREMARIN (Drug), REYVOW | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: WOMENS HEALTH | ||||||
| 03/02/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Diabetes | ||||||
| 02/25/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Bone Health | ||||||
| 02/22/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Diabetes | ||||||
| 02/11/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2021 | Merck Sharp & Dohme Corporation | STEGLUJAN (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/02/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Respiratory | ||||||
| 01/21/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 312 | 424 | $58,570 | $25,499 |
| 2022 | 9 | 281 | 362 | $47,302 | $22,468 |
| 2021 | 2 | 91 | 117 | $15,062 | $2,974 |
| 2020 | 6 | 195 | 248 | $34,461 | $7,132 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 168 | $32,088 | $11,795 | 36.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $8,815 | $5,023 | 57.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 28 | 28 | $4,704 | $2,135 | 45.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $3,588 | $2,044 | 57.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 15 | 15 | $1,965 | $1,132 | 57.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $2,144 | $1,026 | 47.8% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 35 | 35 | $1,470 | $869.05 | 59.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 52 | 85 | $2,715 | $799.68 | 29.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 23 | $1,081 | $675.28 | 62.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 145 | $27,695 | $12,151 | 43.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 36 | 36 | $7,740 | $4,514 | 58.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 18 | 18 | $2,358 | $1,265 | 53.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 13 | $2,496 | $1,234 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 14 | $1,876 | $892.50 | 47.6% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 30 | 30 | $1,260 | $762.82 | 60.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 25 | $1,175 | $698.75 | 59.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 48 | 70 | $2,240 | $671.79 | 30.0% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 11 | 11 | $462.00 | $279.77 | 60.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 56 | 74 | $13,686 | $2,556 | 18.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 35 | 43 | $1,376 | $417.53 | 30.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 83 | 124 | $19,716 | $2,557 | 13.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2020 | 13 | 13 | $3,588 | $2,145 | 59.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 15 | 18 | $3,834 | $897.16 | 23.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 16 | $2,544 | $605.21 | 23.8% |
| G0008 | Administration of influenza virus vaccine | Facility | 2020 | 26 | 26 | $1,222 | $417.18 | 34.1% |
About Dr. Rayeesa Ahmad, M.D
Dr. Rayeesa Ahmad, M.D is a Family Medicine healthcare provider based in Oregon, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2013. The National Provider Identifier (NPI) number assigned to this provider is 1841633708.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rayeesa Ahmad, M.D has received a total of $2,144 in payments from pharmaceutical and medical device companies, with $454.11 received in 2021. These payments were reported across 140 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,129).
As a Medicare-enrolled provider, Ahmad has provided services to 879 Medicare beneficiaries, totaling 1,151 services with total Medicare billing of $58,073. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Oregon, OH
- Active Since 04/10/2013
- Last Updated 11/29/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1841633708
Products in Payments
- CHANTIX (Drug) $263.28
- JANUVIA (Drug) $163.54
- JARDIANCE (Drug) $154.95
- STIOLTO RESPIMAT (Drug) $137.23
- REXULTI (Drug) $85.35
- Ozempic (Drug) $83.15
- Vascepa (Drug) $71.69
- TRULICITY (Drug) $69.47
- INVOKANA (Drug) $63.37
- ENTRESTO (Drug) $60.52
- FARXIGA (Drug) $59.08
- EVENITY (Biological) $52.82
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $51.47
- Prolia (Biological) $51.00
- XIFAXAN (Drug) $49.83
- VIIBRYD (Drug) $48.57
- Livalo (Drug) $41.38
- XARELTO (Drug) $38.31
- PREMARIN (Drug) $35.31
- SPIRIVA RESPIMAT (Drug) $32.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Oregon
Dr. Tara Robinson, M.d, M.D
Family Medicine — Payments: $8,818
Kaleem Gill, Md, MD
Family Medicine — Payments: $7,133
Paul Smith, Md, MD
Family Medicine — Payments: $4,504
Beverly Foltz, Np, NP
Family Medicine — Payments: $3,577
Florentina Chirica, M.d, M.D
Family Medicine — Payments: $2,074
Dr. Kristi Sigler, M.d, M.D
Family Medicine — Payments: $847.39